Study examines AI technologies in healthcare, EU legal frameworks for data reuse in medical AI development, and presents policy recommendations to address implementation challenges.
European Parliament - SANT Subcommittee (Public Health) · EU-wideBriefing on AI use in protein, peptide and nucleic acid design across biopharmaceutical research, industrial biotechnology and vaccine development, with regulatory implications for the EU.
European Parliament - SANT Subcommittee (Public Health) · EU-wideParliamentary amendments to draft legislation establishing a framework for strengthening EU biotechnology and biomanufacturing, amending food, ATMP, clinical trials, veterinary, and related regulations.
European Parliament - SANT Subcommittee (Public Health) · EU-wideParliamentary amendments to draft legislation establishing a framework for strengthening EU biotechnology and biomanufacturing, amending food, ATMP, clinical trials, veterinary, and related regulations.
European Parliament - SANT Subcommittee (Public Health) · EU-widePolicy Department study on data use in public health presented to the Committee, discussing AI's role in healthcare and data reuse frameworks.
European Parliament - SANT Subcommittee (Public Health) · EU-wideOn 14th of July, Members of the Committee on Public Health discussed the highly anticipated draft report on the Medical Devices Regulation. The medical devices sector is vital to healthcare delivery and is an importan...
European Parliament - SANT Subcommittee (Public Health) · EU-wideEuropean Commission President von der Leyen's 2026 State of the Union address highlighted health policy priorities including the European Care deal, climate resilience, AI for health, and mental health.
European Parliament - SANT Subcommittee (Public Health) · EU-wide